Jenelle Krishnamoorthy, Vice President and Head of Global Public Policy, Corporate Affairs, Merck & Co.: “Driving Meaningful and Sustained Progress on AMR”

In this episode Merck’s Jenelle Krishnamoorthy, a member of the CSIS Bipartisan Alliance for Global Health Security, joins Katherine to discuss the growing challenge of antimicrobial resistance (AMR); the importance of incentivizing research and development of new amicrobials, even as there is pressure to use them in a limited way; plans for a United Nations High-Level Meeting on AMR in 2024; and opportunities to improve funding, governance and international collaboration to meet the global threat of AMR in the years to come.